<DOC>
	<DOC>NCT01973933</DOC>
	<brief_summary>This study aims to investigate the pharmacokinetic/pharmacodynamic drug-drug interaction of pyrimethamine and metformin IR after oral administration in healthy male volunteers.</brief_summary>
	<brief_title>Clinical Trial to Investigate the Pharmacokinetic/Pharmacodynamic Drug-Drug Interaction of Pyrimethamine and Metformin IR</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Pyrimethamine</mesh_term>
	<criteria>healthy male subject aged 20 to 45 at screening A body weight in the range of 50 kg (inclusive) 100 kg (inclusive) with ideal body weight range of + 25% subjects who decide to participate voluntarily and write a informed consent form subjects who have clinically significant disease of cardiovascular, respiratory, renal, endocrinological, hematological, gastrointestinal, neurological(central nervous system), psychiatric disorders or malignant tumor Subject judged not eligible for study participation by investigator.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Metformin</keyword>
	<keyword>Pyrimethamine</keyword>
	<keyword>Drug interaction</keyword>
</DOC>